Back
ADMA Biologics 10K Form
Buy
72
ADMA
ADMA Biologics
Last Price:
$17.92
Seasonality Move:
12.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ADMA News And Ratings
See the #1 stock for the next 7 days that we like better than ADMA
ADMA Financial Statistics
Sales & Book Value
| Annual Sales: | $426.5M |
|---|---|
| Cash Flow: | $23.9M |
| Price / Cash Flow: | 47.76 |
| Annual Sales: | $1.48 |
| Price / Book: | 12.54 |
Profitability
| EPS (TTM): | 0.82000 |
|---|---|
| Net Income (TTM): | $197.7M |
| Gross Margin: | $219.6M |
| Return on Equity: | 93.41% |
| Return on Assets: | 51.06% |
ADMA Biologics Earnings Forecast
Key ADMA Biologics Financial Ratios
-
The Gross Profit Margin over the past 15 years for ADMA is 51.48%.
-
The Selling, General & Administrative Expenses for ADMA have been equal to 17.38% of Gross Profit Margin.
-
The Research & Development expenses have been 0.43% of Revenue.
-
The Interest Expense is 7.05% of Operating Income.
-
The Net Earning history of ADMA is 46.35% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 10 years.
ADMA Biologics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ADMA |
| CUSIP: | 000899 |
| Website: | admabiologics.com |
Debt
| Debt-to-Equity Ratio: | 0.21 |
|---|---|
| Current Ratio: | 5.97 |
| Quick Ratio: | 2.76 |
Price-to-Earnings
| Trailing P/E Ratio: | 22.84 |
|---|---|
| Forward P/E Ratio: | 19.27 |
ADMA Technical Analysis vs Fundamental Analysis
Buy
72
ADMA Biologics (ADMA)
is a Buy
Is ADMA Biologics a Buy or a Sell?
-
ADMA Biologics stock is rated a BuyThe current ADMA Biologics [ADMA] share price is $18.50. The Score for ADMA is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.